PNNL-13501 - Pacific Northwest National Laboratory
PNNL-13501 - Pacific Northwest National Laboratory
PNNL-13501 - Pacific Northwest National Laboratory
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Study Control Number: PN99036/1364<br />
Isoprostane-Mediated Tumor Promotion<br />
Thomas J. Weber<br />
Exposure to radiation has been associated with life-span shortening and cancer. The response of a living organism to<br />
radiation can be modified by many factors. The toxic response to ionizing radiation, as well as to numerous chemical<br />
contaminants at DOE sites, is associated with the generation of an oxidative stress. However, the cellular and molecular<br />
mechanisms underlying the carcinogenic response to reactive oxygen species is not known.<br />
Project Description<br />
The toxic response to ionizing radiation, as well as<br />
numerous contaminants identified on DOE sites, is<br />
consistently associated with the generation of an oxidative<br />
stress. Thus, defining the effects of oxidative stress in<br />
mammalian systems is of central interest to DOE.<br />
Oxidative stress is known to play a role in physiologic<br />
and pathophysiologic processes such as cancer, aging, and<br />
neuronal degeneration. It is not clear whether low-level<br />
environmental exposure to radiation sources, or toxicants<br />
whose mechanism of action includes an oxidative stress<br />
component, will increase the risk of cancer.<br />
In the present study, we have investigated whether<br />
prototypical isoprostanes modulate anchorage-dependent<br />
and -independent growth of several in vitro model<br />
systems as an index of tumor promoting activity. We<br />
have found that the isoprostanes modulate anchoragedependent<br />
and -independent growth at extremely low<br />
concentrations (pM-nM), suggesting the biological<br />
activity of these compounds is physiologically relevant.<br />
Introduction<br />
Oxygen free radicals have been implicated in the<br />
pathophysiology of a number of human diseases,<br />
including cancer, atherosclerosis, neurodegenerative<br />
disorders, and aging. Oxidative stress is also central to<br />
the adverse effects of ionizing radiation. Recent<br />
experimental evidence indicates that arachidonic acid may<br />
be converted by reactive oxygen species into a new class<br />
of oxidized lipid metabolites, termed the isoprostanes. In<br />
several model systems, the isoprostanes have been shown<br />
to be biologically active and coupled to signal<br />
transduction pathways associated with carcinogenic<br />
processes. Therefore, it will be important to determine<br />
whether the formation of isoprostanes in response to<br />
ionizing radiation and other environmental associated<br />
toxic insults may increase cancer risk.<br />
The isoprostanes have been shown to signal through the<br />
inositol phospholipid/protein kinase C pathway, which in<br />
turn, is widely implicated in carcinogenic processes.<br />
Thus, the isoprostanes may represent a novel class of<br />
physiologically relevant tumor promoters.<br />
To test this hypothesis, we conducted preliminary studies<br />
to determine whether isoprostanes exhibit tumor<br />
promoting activity using an in vitro model of tumor<br />
promotion (JB6 cell). In addition, we have investigated<br />
whether prototypical isoprostanes modulate anchoragedependent<br />
and -independent growth of several in vitro<br />
model systems as an index of tumor promoting activity.<br />
We have found that the isoprostanes modulate anchoragedependent<br />
and -independent growth at extremely low<br />
concentrations (pM-nM), suggesting the biological<br />
activity of these compounds is physiologically relevant.<br />
Results and Accomplishments<br />
We previously showed that 8-iso-PGF2α increased the<br />
anchorage-independent growth of JB6 cells. We have<br />
extended our investigation to several other in vitro model<br />
systems and a second prototypical isoprostane (8-iso-<br />
PGE2) to determine whether the biological activity of the<br />
isoprostanes was generalizable. Increasing experimental<br />
evidence indicates that vascular smooth muscle cells are<br />
responsive to isoprostanes, and the biological response<br />
isoprostanes may be mediated by a thromboxane A2<br />
(TXA2) receptor (TP), or a putative novel isoprostane<br />
receptor. Studies were conducted to determine whether<br />
8-iso-PGF2α and DDM-PGE2 modulate the proliferation<br />
of smooth muscle cells in vitro. Rat aortic smooth muscle<br />
cells were treated with a range of prostanoid<br />
concentrations and cell proliferation determined using a<br />
picogreen DNA quantitation assay and multiwell<br />
fluorescent plate reader (Cytofluor 4000) according to<br />
manufacturer’s directions. DNA synthesis was increased<br />
in a concentration-dependent fashion by 8-iso-PGF2α, but<br />
Biosciences and Biotechnology 81